Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "UK London Anastasiou D"

From Bioblast
(Replaced content with "{{O2k-Network Lab}}")
Line 1: Line 1:
<nowiki>{{O2k-Network Lab
{{O2k-Network Lab}}
|address=[[Anastasiou D|Anastasiou Dimitrios]],
Β 
Developmental Biology / Physiology and Metabolism / Stem Cell Biology and Developmental Genetics / Systems Biology
Β 
MRC National Institute for Medical Research
Β 
The Ridgeway Mill Hill
Β 
London NW7 1AA, United Kingdom
|city=London
|country=United Kingdom
|Contact=Anastasiou D
|MiPNetLab=Anastasiou D, Williams M
|Team previous=
|Status=
|info=
|weblink=
}}

Revision as of 14:49, 23 March 2016

                



UK London Anastasiou D

Oroboros O2k-Network

O2k-Network
O2k-Network Lab
Address ,
City
State/Prov
Country
Weblink
Contact
Team
Team previous
Status
Oroboros Events
Topics


O2k-Publications

 PublishedReference
Fets 2022 Commun Biol2022Fets L, Bevan N, Nunes PM, Campos S, Dos Santos MS, Sherriff E, MacRae JI, House D, Anastasiou D (2022) MOG analogues to explore the MCT2 pharmacophore, Ξ±-ketoglutarate biology and cellular effects of N-oxalylglycine. https://doi.org/10.1038/s42003-022-03805-y
Fets 2018 Nat Chem Biol2018Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, Silva Dos Santos M, MacRae JI, O'Reilly N, Wright AJ, Benes CH, Courtney KD, House D, Anastasiou D (2018) MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nat Chem Biol 14:1032-42.

O2k-Abstracts

update please